期刊文献+

盐酸苯达莫司汀原料药含量测定方法的比较

Comparative Study on Determination Method of Bendamustine Hydrochloride
下载PDF
导出
摘要 为了比较盐酸苯达莫司汀原料药含量测定的不同方法,建立更加简单、快速的含量测定方法,分别采用HPLC法和非水滴定法对盐酸苯达莫司汀原料药的含量测定进行研究。结果表明,HPLC测定盐酸苯达莫司汀线性范围为10.284~41.1μg/mL,相关系数r=0.99992,最低检测浓度为1.34×10-9 g/mL,精密度(RSD=0.15%)良好;非水滴定法测定具有快速、精密度高、重现性好等优点。两种方法均可作为盐酸苯达莫司汀原料药含量的测定,无显著性差异。 In order to compare different methods for the content determination of bendamustine hydrochloride,and to establish a more simple and rapid method,HPLC and non-aqueous titration were used to determine the content of bendamustine hydrochloride.The results showed the calibration curve of bendamustine hydrochloride was linear within 10.284~41.1μg/mL,related coefficient was 0.99992,the least detecting concentration was 1.34×10-9 g/mL,and the method was of precision(RSD=0.15%).The non-aqueous titration method has the advantages of fast speed,high precision and good reproducibility.The two methods can be used to determine the content of bendamustine hydrochloride.
作者 沈红梅 SHEN Hong-mei(Kelun Pharmaceutical Research Institute Co.,Ltd.,Sichuan Chengdu 611130,China)
出处 《广州化工》 CAS 2021年第3期55-57,共3页 GuangZhou Chemical Industry
关键词 盐酸苯达莫司汀 含量测定 高效液相色谱法 非水滴定法 bendamustine hydrochloride determination HPLC nonaqueous titration
  • 相关文献

参考文献4

二级参考文献34

  • 1KRUEGER W, KRUEGER G. 4-[ 1-Methyl-5-bis [ (2-chloroethyl) amino ] - 2-benzimidazolyl ] butyric acid:DD, 159877 [ P]. 1983 - 04 - 13.
  • 2DREYLING M. Bendamusfine is a hybrid antimetabo- lite and alkylating agent offering new therapeutic op- tions for the treatment of non-Hodgkin lymphomas [ J]. Dreyling Hematology Meeting Reports, 2008,2 (5) :123 - 124.
  • 3BLUMEL S, GOODRICH A, MARTIN C. Bendarnustine:a novel cytotoxic agent for hematologic malignancies[J]. Clin J Oncol Nuts,2008,12(5) :799 - 806.
  • 4CHESON BD, RUMMEL MJ. Bendamustine : rebirth of an olddrug[J]. J Clin Oncol, 2009, 27(9) : 1492 - 1501.
  • 5DREYLING M. Bendamustine is a hybrid anti-metabolite and al-kylating agent offering new therapeutic options for the treatment ofnon-Hodgkin lyraphomas[ R]. Hematol Meeting Reports, 2008,2(5) :123 - 124.
  • 6TAGEJA N , NAGI J. Bendamustine : something old, somethingnew[ J ]. Cancer Chemother Pharmacol, 2010,66 ( 3 ) : 413 -423.
  • 7CEPHALON INC. Treanda( bendamustine hydrochloride ) pack-age insert[ S]. Frazer, PA , 2009.
  • 8MATTHIAS M,PREISS R,SOHR R, et al. Pharmacokinetics ofbendamustine in patients with malignant tumors [ abstract ] [ J ].Proc Am Soc Clin Oncol, 1995,14:458.
  • 9PREISS R, SOHR R,MATTHIAS M, et al. Pharmacokinetics ofbendamustine ( Cytostasan) in patients[ J ] . Pharmazie, 1985 ,40(11):782 -784.
  • 10RASSCHAERT M, SCHRIJVERS D, VAN DEN BRANDE J,etal. A phase I study of bendamustine hydrochloride administeredday 1+2 every 3 weeks in patients with solid tumors [ J ]. Br JCancer, 2007, 96(11) : 1692 - 1698.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部